Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for preventing or treating gleevec-resistant leukemia containing ginsenoside F1 or ginsenoside Rg3 as an active ingredient

Pharmaceutical composition for preventing or treating gleevec-resistant leukemia containing ginsenoside F1 or ginsenoside Rg3 as an active ingredient

US Patent 10376530 · Granted Aug 13, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Barrier rib for image display device, manufacturing method therefor, and image d2024
Color filter, and method of manufacturing same2023
Microorganism having minimal genome and method of producing the same2022
Electroluminescent device with improved luminous efficiency and viewing angle an2022
Increased production of ginsenosides through yeast cell organelle improvement2021
Increased production of ginsenosides through improvement of protein-folding mach2021
Method for enhancing immunity using ginsenoside F1 as an active ingredient2020
Method for enhancing immunity using ginsenoside F1 as an active ingredient2020
Multimeric antimicrobial peptide complex which is displayed on cell surface2019
Composition for preventing or treating vascular leak syndrome2019
Composition for preventing or treating cervical cancer including gypenoside LXXV2019
Composition for treating wound comprising gypenoside LXXV2019